Increased levels of mevalonate have been observed in several tumor cell lines to be associated with increased cellular proliferation and tumor growth [51], and altered levels of HMG-CoA synthase have been described in in HCC [52]. This evidence concerns the gene HMGCS2 and hepatocellular carcinoma.